Among the most polarizing stocks on Wall Street is one of it’s most famous — Tesla (TSLA). Since the beginning of last year, shares have climbed or dropped at least 10% more than a dozen times, as some in the investment community look at the stock as a can’t-lose, with others thinking there’s no chance the […]

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Moleculin Biotech (MBRX), with a price target of $3. The company’s shares opened today at $1.27. McCarthy commented: “Following last month’s clearance to begin its European clinical trial of WP1220 (STAT3 inhibitor) in the topical treatment of cutaneous T-cell lymphoma […]

In the entire history of the United States, consumers have never been in so much debt.  And that would not be a crisis as long as the vast majority of us were regularly making our debt payments, but as you will see below delinquency levels are starting to rise to extremely alarming levels.  In fact, […]